FDA approves Ixifi third Remicade biosimilar

The FDA has approved the third biosimilar to infliximab infliximabqbtx for all eligible indications of the biologic product according to a company press release.Ixifi infliximabqbtx Pfizer a biosimilar to Remicade infliximab Janssen is a chimeric humanmuri...